FR2227868A1 - - Google Patents

Info

Publication number
FR2227868A1
FR2227868A1 FR7415029A FR7415029A FR2227868A1 FR 2227868 A1 FR2227868 A1 FR 2227868A1 FR 7415029 A FR7415029 A FR 7415029A FR 7415029 A FR7415029 A FR 7415029A FR 2227868 A1 FR2227868 A1 FR 2227868A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7415029A
Other versions
FR2227868B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of FR2227868A1 publication Critical patent/FR2227868A1/fr
Application granted granted Critical
Publication of FR2227868B1 publication Critical patent/FR2227868B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7415029A 1973-05-03 1974-04-30 Expired FR2227868B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/356,975 US4101662A (en) 1973-05-03 1973-05-03 Method for inhibiting emesis and compositions therefor

Publications (2)

Publication Number Publication Date
FR2227868A1 true FR2227868A1 (fr) 1974-11-29
FR2227868B1 FR2227868B1 (fr) 1977-09-09

Family

ID=23403763

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7415029A Expired FR2227868B1 (fr) 1973-05-03 1974-04-30

Country Status (7)

Country Link
US (1) US4101662A (fr)
JP (2) JPS6156227B2 (fr)
AU (1) AU471020B2 (fr)
BE (1) BE814396A (fr)
FR (1) FR2227868B1 (fr)
GB (1) GB1429751A (fr)
IL (1) IL44721A (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448531A1 (fr) * 1979-02-09 1980-09-05 Richardson Merrell Inc Nouveaux derives de 4-(naphtylmethyl)piperidine, utiles notamment comme agents antipsychotiques et leur procede de preparation
FR2468592A1 (fr) * 1979-10-27 1981-05-08 Richardson Merrell Inc Nouvelles (alkyl-4 aroyl-4 piperidino)-4 butyrophenones utiles notamment comme medicaments antipsychotiques, procedes et intermediaires, pour leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
EP0202164A1 (fr) * 1985-05-14 1986-11-20 Synthelabo Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP0288563A1 (fr) * 1986-09-30 1988-11-02 Eisai Co., Ltd. Derives d'amines cycliques
EP0318029A2 (fr) * 1987-11-27 1989-05-31 Eisai Co., Ltd. Amines cycliques et compositions pharmaceutiques les renfermant
US5196439A (en) * 1987-11-27 1993-03-23 Eisai Co., Ltd. Piperidine compounds useful to treat cerebrovascular diseases
EP0661266A1 (fr) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Composés cycliques aminés substitués comme 5HT2 antagonistes
US5523307A (en) * 1987-11-27 1996-06-04 Eisai Co., Ltd. Cyclic amine and pharmacological composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283404A (en) * 1979-09-04 1981-08-11 Richardson-Merrell Inc. Aroylethenylpiperidinobutyrophenone antipsychotic agents
US4284636A (en) * 1979-09-04 1981-08-18 Richardson-Merrell Inc. Cinnamoylpiperidinobutyrophenone antipsychotic agents
US5021428A (en) * 1985-07-02 1991-06-04 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds for the prophylactic treatment of migraine
JP2573195B2 (ja) * 1986-09-30 1997-01-22 エーザイ株式会社 環状アミン誘導体
US4870083A (en) * 1987-11-24 1989-09-26 Merrell Dow Pharmaceuticals Inc. 1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants
US5162342A (en) * 1988-01-21 1992-11-10 Merrell Dow Pharmaceuticals Inc. Use of 1,4-disubstituted-piperidinyl compounds for analgesia and muscle relaxation
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128278A (en) * 1964-04-07 Substituted l
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US3852455A (en) * 1970-11-27 1974-12-03 Richardson Merrell Inc 4-{8 4({60 hydroxybenzyl)piperidino{9 -4-fluorobutyrophenone derivatives as tranquilizers

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448531A1 (fr) * 1979-02-09 1980-09-05 Richardson Merrell Inc Nouveaux derives de 4-(naphtylmethyl)piperidine, utiles notamment comme agents antipsychotiques et leur procede de preparation
FR2468592A1 (fr) * 1979-10-27 1981-05-08 Richardson Merrell Inc Nouvelles (alkyl-4 aroyl-4 piperidino)-4 butyrophenones utiles notamment comme medicaments antipsychotiques, procedes et intermediaires, pour leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
EP0202164A1 (fr) * 1985-05-14 1986-11-20 Synthelabo Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
FR2581993A1 (fr) * 1985-05-14 1986-11-21 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
EP0288563A1 (fr) * 1986-09-30 1988-11-02 Eisai Co., Ltd. Derives d'amines cycliques
EP0288563A4 (en) * 1986-09-30 1990-09-26 Eisai Co., Ltd. Cyclic amine derivatives
EP0318029A2 (fr) * 1987-11-27 1989-05-31 Eisai Co., Ltd. Amines cycliques et compositions pharmaceutiques les renfermant
EP0318029A3 (en) * 1987-11-27 1990-09-26 Eisai Co., Ltd. Cyclic amine and pharmacological composition
US5196439A (en) * 1987-11-27 1993-03-23 Eisai Co., Ltd. Piperidine compounds useful to treat cerebrovascular diseases
US5523307A (en) * 1987-11-27 1996-06-04 Eisai Co., Ltd. Cyclic amine and pharmacological composition
EP0661266A1 (fr) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Composés cycliques aminés substitués comme 5HT2 antagonistes

Also Published As

Publication number Publication date
FR2227868B1 (fr) 1977-09-09
IL44721A (en) 1977-06-30
JPS59152371A (ja) 1984-08-31
US4101662A (en) 1978-07-18
AU6851674A (en) 1975-11-06
JPS6131099B2 (fr) 1986-07-17
AU471020B2 (en) 1976-04-08
IL44721A0 (en) 1974-06-30
JPS6156227B2 (fr) 1986-12-01
GB1429751A (en) 1976-03-24
JPS5018477A (fr) 1975-02-26
BE814396A (fr) 1974-08-16

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
FR2227868B1 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU466283B2 (fr)
AU477823B2 (fr)
AU447540B2 (fr)
AU471461B2 (fr)
AU461342B2 (fr)
AU477824B2 (fr)
AR210729A1 (fr)
AR193950A1 (fr)
AU476873B1 (fr)
AU1891376A (fr)
AU480590A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse